Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06382246

The Acute Effect of "Exercise Snacks" on Glycemic Responses in Individuals With Type 2 Diabetes.

The Acute Effect of "Exercise Snacks" on Glycemic Responses in Individuals With Type 2 Diabetes: a Randomized Controlled Crossover Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
30 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To conduct a randomized crossover trial to determine the acute impact of exercise snacks on glycemic control in physically inactive individuals living with type 2 diabetes using continuous glucose monitoring.

Detailed description

Participants will perform two, 48-hour experimental conditions separated by 24 hours while wearing a continuous glucose monitor to measure glycemic responses. The order of the trials will be randomized for each participant. The two trials will include an exercise condition (EX) and a control, non-exercise condition (CON). During the EX trial, participants will perform four exercise snacks per day on two consecutive days (i.e., Monday and Tuesday). Each exercise snack will be 1-minute in duration and consist of bodyweight style exercise performed with vigorous effort. During the CON trial, participants will be asked to refrain from any structured exercise during two consecutive days (i.e., Thursday and Friday). All meals will be provided to participants during the two 48-hour trials and will be standardized for a given participant. There will be a one-day wash out period in between the completion of both trials for all participants.

Conditions

Interventions

TypeNameDescription
OTHERExercise snacksBodyweight-style exercise snacks lasting 1-minute each performed with vigorous effort 4 times per day on two consecutive days.

Timeline

Start date
2024-04-20
Primary completion
2025-07-15
Completion
2025-07-15
First posted
2024-04-24
Last updated
2024-05-08

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06382246. Inclusion in this directory is not an endorsement.